endolysin has been researched along with Eczema, Atopic in 3 studies
lysine-4,4,5,5-d4 : A deuterated compound that is lysne in which the methylene hydrogens at positions 4, 4, 5 and 5 have been replaced by deuterium.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Moreau, M | 1 |
| Seité, S | 1 |
| Aguilar, L | 1 |
| Da Cruz, O | 1 |
| Puech, J | 1 |
| Frieling, J | 1 |
| Demessant, A | 1 |
| Totté, J | 1 |
| de Wit, J | 2 |
| Pardo, L | 1 |
| Schuren, F | 1 |
| van Doorn, M | 1 |
| Pasmans, S | 1 |
| Totté, JEE | 1 |
| van Mierlo, MMF | 1 |
| van Veldhuizen, J | 1 |
| van Doorn, MBA | 1 |
| Schuren, FHJ | 1 |
| Willemsen, SP | 1 |
| Pardo, LM | 1 |
| Pasmans, SGMA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic Dermatitis[NCT02840955] | 100 participants (Actual) | Interventional | 2016-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for endolysin and Eczema, Atopic
| Article | Year |
|---|---|
Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial).
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Clinical Protocols; Derma | 2017 |
Endolysin treatment against Staphylococcus aureus in adults with atopic dermatitis: A randomized controlled trial.
Topics: Adult; Dermatitis, Atopic; Double-Blind Method; Endopeptidases; Female; Humans; Male; Middle Aged; R | 2019 |
1 other study available for endolysin and Eczema, Atopic
| Article | Year |
|---|---|
Topical S. aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis.
Topics: Adult; Child; Dermatitis, Atopic; Endopeptidases; Humans; Methicillin-Resistant Staphylococcus aureu | 2021 |